These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16942120)

  • 21. Willingness to pay for a QALY: theoretical and methodological issues.
    Gyrd-Hansen D
    Pharmacoeconomics; 2005; 23(5):423-32. PubMed ID: 15896094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The integration of claims to health-care: a programming approach.
    Anand P
    J Health Econ; 2003 Sep; 22(5):731-45. PubMed ID: 12946456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. QALYs and ageism: philosophical theories and age weighting.
    Tsuchiya A
    Health Econ; 2000 Jan; 9(1):57-68. PubMed ID: 10694760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health utility indices and equity considerations.
    Bleichrodt H
    J Health Econ; 1997 Feb; 16(1):65-91. PubMed ID: 10167345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concerns for severity in priority setting in health care: a review of trade-off data in preference studies and implications for societal willingness to pay for a QALY.
    Nord E; Johansen R
    Health Policy; 2014 Jun; 116(2-3):281-8. PubMed ID: 24690334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. QALYs: are they helpful to decision makers?
    McGregor M; Caro JJ
    Pharmacoeconomics; 2006; 24(10):947-52. PubMed ID: 17002477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QALYs and the equity-efficiency trade-off.
    Wagstaff A
    J Health Econ; 1991 May; 10(1):21-41. PubMed ID: 10113661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Illustrating potential efficiency gains from using cost-effectiveness evidence to reallocate Medicare expenditures.
    Chambers JD; Lord J; Cohen JT; Neumann PJ; Buxton MJ
    Value Health; 2013 Jun; 16(4):629-38. PubMed ID: 23796298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A welfare economic approach to measure outcomes in stuttering: comparing willingness to pay and quality adjusted life years.
    Franic DM; Bothe AK; Bramlett RE
    J Fluency Disord; 2012 Dec; 37(4):300-13. PubMed ID: 23218213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health Economics as Rhetoric: The Limited Impact of Health Economics on Funding Decisions in Four European Countries.
    Franken M; Heintz E; Gerber-Grote A; Raftery J
    Value Health; 2016 Dec; 19(8):951-956. PubMed ID: 27987645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On individual preferences and aggregation in economic evaluation in healthcare.
    Liljas B; Lindgren B
    Pharmacoeconomics; 2001; 19(4):323-35. PubMed ID: 11383750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the welfare theoretic foundation of cost-effectiveness analysis-the case when survival is not affected.
    Liljas B
    Eur J Health Econ; 2010 Feb; 11(1):5-13. PubMed ID: 19255794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incorporating sign-dependence in health-related social welfare functions.
    Attema AE
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):223-8. PubMed ID: 25543906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dollars may not buy as many QALYs as we think: a problem with defining quality-of-life adjustments.
    Fryback DG; Lawrence WF
    Med Decis Making; 1997; 17(3):276-84. PubMed ID: 9219187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should we aggregate relative or absolute changes in QALYs?
    Johannesson M
    Health Econ; 2001 Oct; 10(7):573-7. PubMed ID: 11747040
    [No Abstract]   [Full Text] [Related]  

  • 37. Allocational and distributional aspects of future immigration to Western Europe.
    Straubhaar T
    Int Migr Rev; 1992; 26(2):462-83. PubMed ID: 12285268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economics, QALYs and medical ethics: a practical agenda?
    Robinson R
    Health Care Anal; 1995 Aug; 3(3):229-32. PubMed ID: 10151643
    [No Abstract]   [Full Text] [Related]  

  • 39. Is the aim of the English health care system to maximize QALYs?
    Shah K; Praet C; Devlin N; Sussex J; Appleby J; Parkin D
    J Health Serv Res Policy; 2012 Jul; 17(3):157-63. PubMed ID: 22767891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Willingness to pay and the valuation of programmes for the prevention and control of influenza.
    Birch S; Gafni A; O'Brien B
    Pharmacoeconomics; 1999; 16 Suppl 1():55-61. PubMed ID: 10623377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.